Search results
Treatments for ER-Positive PR-Positive HER2-Negative Breast Cancer
Healthline· 2 weeks agoER-positive PR-positive HER2-negative breast cancer cells have both hormone receptors but don’t...
Blocking Gene May Halt Growth of Some Breast Cancers
Technology Networks· 2 weeks agoShutting down a gene called PRMT5 stopped metastatic estrogen receptor-positive (ER+) breast cancer cells from growing after they acquired resistance to...
Maddy Baloy, 26-year-old who documented her terminal cancer journey on TikTok, dies
TODAY via Yahoo News· 3 days agoIn a post shared to her Instagram page, Baloy recalled how the stomach pain she first experienced in...
New treatment available for people impacted by this type of skin cancer
News Channel 5 Cleveland· 9 hours agoData from the American Cancer Society estimates more than 100,000 new melanoma cases will be...
US Breast Cancer Mortality—Reply
Journal of the American Medical Association· 2 weeks agoIn Reply Dr Jatoi suggests that a reduction in the incidence of ER-negative breast cancer over the past decades could have contributed to the decline in ...
Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032
WTNH-TV New Haven· 4 days agoAccording to a "highly troubling" new study, the rising number of cancer cases in young people is...
"It Blows My Mind Thinking About It": 23 Boomers Are Revealing The "Wild" But Common Everyday...
BuzzFeed via Yahoo News· 22 hours agoArmstrong Roberts 22."Our family doctor was a chain smoker and kept an ashtray in every exam room....
Capturing humanity at its finest
China Daily· 1 week agoAfter successfully receiving chemo and radiotherapy, her cancer returned in 2020, and before she underwent surgery, she invited photographer Wang Naigong to take family photos ...
IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
WKBN 27 Youngstown· 1 hour ago...dose escalation and targeting development of joint Amgen / IDEAYA publication strategy in 2024First-patient-in (FPI) for Phase 1 trial of IDE397 in combination with Gilead's Trodelvy® in MTAP bladder cancer targeted mid-year 2024Targeting initial Phase 2 expansion for IDE161 in HRD solid tumors...
Pipeline Moves: Investigator-led trial of Lilly’s merestinib in solid tumours terminated
Clinical Trials Arena via Yahoo Finance· 1 week agoThe Phase I trial’s (NCT05080842) status was updated from active, not recruiting to terminated on...
